Toh, Ming Ren
Ng, Gerald Xuan Zhong
Goel, Ishita
Lam, Shao Wei
Wu, Jun Tian
Lee, Chun Fan
Ong, Marcus Eng Hock
Matchar, David Bruce
Tan, Ngiap Chuan
Loo, Chian Min
Koh, Mariko Siyue
Funding for this research was provided by:
Glaxosmithkline
Article History
Received: 19 June 2024
Accepted: 1 October 2024
First Online: 3 November 2024
Competing interests
: Ming Ren Toh reports no conflict of interest. Gerald Xuan Zhong Ng reports no conflict of interest. Ishita Goel reports no conflict of interest. Shao Wei Lam reports no conflict of interest. Jun Tian Wu reports no conflict of interest. Chun Fan Lee reports no conflict of interest. Marcus Eng Hock Ong reports no conflict of interest. David Bruce Matchar reports no conflict of interest. Ngiap Chuan Tan reports no conflict of interest. Chian Min Loo reports no conflict of interest. Mariko Siyue Koh reports grant support from Astra-Zeneca, and honoraria for lectures and advisory board meetings paid to her hospital (Singapore General Hospital) from GlaxoSmithKline, Astra-Zeneca, Novartis, Sanofi, Boehringer Ingelheim and Roche outside the submitted work.
: Ethics board approval was obtained as part of the SDG-CARE collaboration, prior to developing the SCDM (SingHealth Centralized Institutional Review Board Ref No. 2017/2950). Informed consent has been waived by SingHealth Centralized Institutional Review Board Ref No. 2017/2950.